SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

Anixa Biosciences, Inc. (ANIX) News

Track canonical SquawkNews coverage tagged to ANIX, Anixa Biosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ANIX Asset equity Sector Markets 90 days 2 Last 3.21 Updated Jul 06, 2026, 01:02 PM UTC Open live news feed
L Anixa Biosciences Treats First Patient in Fifth Cohort of Ovarian Cancer CAR-T Clinical Trial () -- Anixa Biosciences (ANIX) said Monday the first patient has been treated in the fifth cohort of its phase 1 trial evaluating its novel CAR-T therapy lira-cel, which targets follicle stimulating hormone receptor for EQUITY | Jul 06, 2026, 01:02 PM UTC H ANIX Reports Positive Trial Data Anixa Biosciences reports positive data from breast cancer vaccine phase 1 trial and CAR-T phase 1 trial EQUITY | Jun 26, 2026, 01:11 PM UTC